4.6

CVE-2001-0641: immunix

CVSS: 4.6v2.0MediumModified
Published 09-03-2002Last modified 08-08-2024
Open JSON

Vulnerability summary

CVE-2001-0641 is a medium (CVSS 4.6) vulnerability in immunix. EPSS estimates a 1.26% chance of exploitation in the next 30 days, higher than 69% of scored vulnerabilities. 2 public exploits are recorded.

Overall risk
29/100
0100
Medium · default modelHow is this calculated?
CVSS score
4.6/10
010
Medium · v2.0 (NVD)
EPSS score
1.26%
0%100%
Low · 0.00 pp in 30 days
KEVNot listedIn no KEV catalog
RansomwareNone recordedNo known use recorded
Public exploits2reference, exploit-database

Timeline

  1. 09-03-2002
    PublishedVulnerability first disclosed.
  2. 08-08-2024
    Last modifiedVulnerability information updated.

Description

Buffer overflow in man program in various distributions of Linux allows local user to execute arbitrary code as group man via a long -S option.

CVSS metrics

1 score · 1 source · 1 version

EPSS trend

Probability

1.26%

Chance of exploitation in the next 30 days

Percentile

69%

Versus all other CVEs

30-day change

0.00 pp

From 1.26% on 18-09-2026

18-09-202618-10-2026
EPSS score
1.26%

Known exploited

Compare KEV catalogs

Not in any of the 3 tracked catalogs.

Public exploits

2 found
  • referenceUnverified

    Exploit Reference (securityfocus.com)

    Maturity: unknown

  • exploit-databaselocallinuxVerified

    Immunix OS 6.2/7.0 / RedHat 5.2/6.2/7.0 / SuSE Linux 6.x/7.0/7.1 - 'Man -S' Heap Overflow

    Maturity: weaponized

Weaknesses

CWE · root cause

No weakness data has been published for this record.

Affected systems

Immunix1 product
Redhat1 product
Suse1 product

3 vendors · 3 products

References

6 links